BioIncept LLC   Report issue

For profit Phase 2
Founded: Cherry Hill NJ United States (1996)

Organization Overview

First Clinical Trial
2014
NCT02239562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

BioIncept LLC